Allergan plc operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Allergan plc with three other
companies in this sector in UNITED STATES :
Novo Nordisk As
sales of $18.27 billion
of which 84%
was Diabetes and obesity),
Teva Pharmaceutical Industries Limited
of which 51%
was North America), and
Takeda Pharmaceutical Company Limited
of which 97%
was Pharmaceutical Business).
Allergan plc reported sales of $16.09 billion
December of 2019.
a very small
increase of 1.9%
versus 2018, when the company's sales were $15.79 billion.
Sales of Us General Medicine saw an increase
that was more than double the company's growth rate: sales were up
9.6% in 2019, from
$5.32 billion to $5.83 billion.
Not all segments of Allergan plc experienced an increase in sales in 2019:
sales of Other fell 19.0% to $32.00 million.
(However, this segment's sales were only a very small portion of the company's overall sales).
Allergan plc also experienced decreases in sales in
Us Specialized Therapeutics (down 1.4% to $6.82 billion)
International (down 2.9% to $3.40 billion)